Clinical Trial Update: Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy [NA]

View source ↗

Summary

This completed clinical trial evaluated patient-reported outcomes and physical activity in Japanese patients with HR+/HER2- advanced breast cancer treated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hr-positive Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2024-11-22